基本信息
浏览量:23
职业迁徙
个人简介
Dr. Wei Zhang obtained his PhD from China pharmaceutical university in 2008. He
proceeded to his post-doctoral training at Department of pharmacology from Yale
University School of Medicine during 2008-2012. In the YaleUniversity, his study
focused on phytochemical and Pharmacokinetic studies of PHY906 (Chinese
botanical formulation of Huang Qin Tang). He participated in the PHY906 phase I/II
clinical trials in U.S. as a modulator of capecitabine and Irinotecan. He has published
several well-recognized research articles including identification of PHY906
chemicals and their metabolites in patient plasma and determination of all
ribonucleotides and Deoxyribonucleotides. He also joined the study of mechanism of
phy906 and published research article in the journal of Science Translational
Medicine as a co-author, which has been reported by the Nature News & Comment
and Science Daily News. In August 2012, he moved to Macau Institute for Applied
Research in Medicine and Health,Macau University of Science and Technology as an
assistant professor.
研究兴趣
论文共 148 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Analysis and Testingpp.1-8, (2024)
Bioorganic Chemistry (2024): 107111-107111
Yue Wang, Fei Yu,Qinghua Liu,Caiyun Wang,Guoyuan Zhu,Liping Bai, Shuai Shi,Yunfeng Zhao,Zhihong Jiang,Wei Zhang
FOOD CHEMISTRY (2024): 137192-137192
JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINEno. 1 (2024): 11-24
BIOORGANIC CHEMISTRY (2024)
RSC ADVANCESno. 2 (2024): 1009-1017
Food chemistry (2023): 137986-137986
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn